Purification is typically the most taxing and expensive stage of vaccine production. State-of-the-art affinity chromatography technologies have the potential to streamline vaccine purifications—and, therefore, accelerate vaccine development and ultimately their manufacture. This ebook explores in depth the use of affinity chromatography to accelerate vaccine development (chapter 1), to manufacture messenger RNA vaccines (chapter 2) and virus-like-particle vaccines (chapter 3), and to develop malaria vaccines (chapters 4 and 5).
Copyright © 2024 American Chemical Society | 1155 Sixteenth Street NW | Washington, DC 20036 | View our Privacy Policy